Endocrine Resistance-Causing Genes in Breast Cancer | Oncotarget

Endocrine Resistance: Mechanisms and Treatment StrategiesПодробнее

Deciphering Mechanisms of Action of Progesterone in Breast Cancer | OncotargetПодробнее

Epigenetic Therapy Targets the 3D Epigenome in Endocrine-Resistant Breast CancerПодробнее

3D Epigenome Remodelling in Endocrine Resistant Breast CancerПодробнее

Continuous Abemaciclib Treatment Leads to Breast Cancer Inhibition | OncotargetПодробнее

Oncotarget: Prognostic role of elevated mir-24-3p in breast cancerПодробнее

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cellsПодробнее

Oncotarget: Combination Therapeutics Inhibit Breast Cancer ResistanceПодробнее

Oncotarget: CRISPR Used in Triple Negative Breast Cancer ResearchПодробнее

Endocrine-resistance breast cancersПодробнее

Overcoming Endocrine Resistance in ER-Positive Metastatic Breast CancerПодробнее

Treatment of endocrine resistant breastcancer By Dr. Amin Eltigani (Day 1)Подробнее

Therapeutic strategies to maximize sensitivity to endocrine therapy in breast cancerПодробнее

Targeted sequencing in endocrine refractory breast cancerПодробнее

Dr. Ellis on Resistance to Endocrine Therapy in HR+ Metastatic Breast CancerПодробнее

Addressing the Challenge of Endocrine-Resistant Breast CancerПодробнее

Prognostic and predictive potential of CXCL11 in endocrine resistance in breast cancerПодробнее

Joanna Achinger-Kawecka: "3D Epigenome Remodelling in the Endocrine-Resistant Breast Cancer"Подробнее

Oncotarget: Clinical Trial of P10s-PADRE Vaccine in Breast CancerПодробнее